Jump to content

PubMed RSS Feed - -Association Between Skin Findings and Ocular Signs in Rosacea


rss

Recommended Posts

Turk J Ophthalmol. 2021 Dec 28;51(6):338-343. doi: 10.4274/tjo.galenos.2021.05031.

ABSTRACT

OBJECTIVES: To report the most frequent signs in ocular rosacea and evaluate their association with skin findings.

MATERIALS AND METHODS: Fifty-one patients diagnosed with rosacea by a trained dermatologist were evaluated by an ocular surface specialist. A complete ophthalmological examination was performed.

RESULTS: In our study, the prevalence of ocular signs in patients with rosacea was 74.5%. The average age at presentation was 50 years and women were more affected than men. The most common findings were lid margin erythema, meibomian gland dysfunction, and blepharitis. Fifteen patients had decreased visual acuity due to complications related to rosacea such as leukoma and corneal neovascularization. Interestingly, patients that had the lowest visual acuity presented with dermatological signs of papules and pustules (p=0.001) and rhinophyma (p=0.023). Two patients who showed subepithelial fibrosis and fornix foreshortening were diagnosed as having ocular cicatricial pemphigoid (OCP) by immunohistopathological analysis of conjunctival specimens.

CONCLUSION: Ocular compromise is common in rosacea. Our study shows that there might be a relationship between the severity of ocular involvement and certain subtypes of cutaneous disease. Rosacea and OCP may coexist. In cases that present with conjunctival fibrotic changes, a diagnostic biopsy is mandatory.

PMID:34963260 | DOI:10.4274/tjo.galenos.2021.05031

{url} = URL to article

Other Co-Existing Conditions with Rosacea

Phenotype 6 Rosacea

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...

Important Information

Terms of Use